Preclinical data showed PSMA CAR NK92 cells exhibit remarkable cytotoxicity against castration‐resistant prostate cancer cells via inducing ferroptosis, and this effect can be augmented synergistically by RSL‐3, which drives ferroptosis through GPX4 inhibition and ROS production.166. This evidence concerns the gene FOLH1 and prostate cancer.